Spike RBD Antibody (2847A) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # FAB11198D
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
Flow Cytometry, Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2847A
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CHO-derived sars-cov-2 Spike RBD protein
Arg319-Phe541
Accession # YP_009724390.1
Arg319-Phe541
Accession # YP_009724390.1
Specificity
Detects Sars-cov-2 Spike RBD protein in Elisas and Western Blot
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Spike RBD Antibody (2847A) [DyLight 350]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Spike RBD
Long Name
Spike Receptor Binding Domain
Additional Spike RBD Products
Product Documents for Spike RBD Antibody (2847A) [DyLight 350]
Product Specific Notices for Spike RBD Antibody (2847A) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...